SIA FUNDS, EL FONDO QUE CONFÍA EN GRÍFOLS SE POSICIONA EN CONTRA DE LA OPA .: HALAVEN BY EISAI ( ERIBULIN 7389-LF 2.1mg/m2 ) In Combination With OPDIVO BY BRISTOL_MYERS ( NIVOLUMAB 360mg Q3W ) Showed Notable Antitumor Activity As SECOND-LINE Therapy For Small_Cell_Lung